During the past decade, Federal State Budget Scientific Institution conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Federal State Budget Scientific Institution" #1 sponsor was "Actelion" with 7 trials, followed by "Kowa Research Institute, Inc." with 2 trials sponsored, "American Regent, Inc." with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "International Foundation for Development of Medical Science and Education Healthy Heart" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Federal State Budget Scientific Institution" #1 collaborator was "Medidata Solutions" with 2 trials as a collaborator, "AcitGraph" with 1 trials as a collaborator, "Almac Clinical Technologies, LLC" with 1 trials as a collaborator, "Chiltern International Ltd." with 1 trials as a collaborator and "Covance Central Laboratory Services, LP" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Federal State Budget Scientific Institution" are "Pulmonary Arterial Hypertension" (3 trials), "Chronic Thromboembolic Pulmonary Hypertension" (2 trials), "Severe Hypertriglyceridemia" (2 trials), "Angina" (1 trials) and "Asthma" (1 trials). Many other conditions were trialed in "Federal State Budget Scientific Institution" in a lesser frequency.

Most popular intervention types in "Federal State Budget Scientific Institution" are "Drug" (12 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Macitentan" (2 trials) and "Placebo (for K-877)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Federal State Budget Scientific Institution" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Federal State Budget Scientific Institution". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Federal State Budget Scientific Institution, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Federal State Budget Scientific Institution, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Federal State Budget Scientific Institution has several departments that took part in Clinical trials: "Kemerovo Cardiology Dispensary" - 5 trials